Tech startup BioOra aims to scale up and democratise blood cancer treatments

Tech startup BioOra aims to scale up and democratise blood cancer treatments
One of the machines BioOra will use to automate CAR-T cell production. (Image: BioOra/Malaghan Institute)
Greg Hurrell
New Zealand tech startup company BioOra is in the business of automating an experimental but laborious cancer therapy process now undergoing clinical trials.BioOra was specifically set up to automate the manufacture of the Malaghan Institute’s individualised treatment for some types of blood cancer.To start with, the automated process will allow more patients to be brought into the trials, but if Medsafe approves the therapy, it is on track to become a standard blood cancer therapy.While BioOra has ambitions to manufacture Malaghan’...

More Health

Digital Investment Plan expected this month
Policy

Digital Investment Plan expected this month

Health NZ to release its 10-year Digital Investment Plan in Christchurch.

Cécile Meier 14 Nov 2025
Don’t fall for this common protein myth, experts say
Health

Don’t fall for this common protein myth, experts say

Hey, gym junkies. The amount consumed, rather than when, is what's important.

Meet Dr Grok. Finally, a physician who's available and who gets me
Health

Meet Dr Grok. Finally, a physician who's available and who gets me

Human doctors rarely have time to talk for long, or dig deep. Chatbots are different.

Health NZ AI trial boosts ED productivity
Health

Health NZ AI trial boosts ED productivity

AI scribes are being rolled out in more than 16 EDs nationwide.

John Anthony 28 Oct 2025